Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy

Clinical trial NCT03888950 · RECRUITING

Trial details

NCT number: NCT03888950
Sponsor: Centre Hospitalier Universitaire de Nice
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2020-11-24
Primary completion: 2022-11-24
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.